BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2002
View Archived Issues
New data on a fixed combination of calcipotriol/betamethasone dipropionate in psoriasis
Read More
T-cell depletion by alefacept reported effective in psoriatic lesions
Read More
Antidiabetic efficacy of GLP-1 derivative NN-2211 in minipigs
Read More
Preclinical antitumor activity of FK-228
Read More
Kiadis and Biofrontera collaborate to develop treatments for neuropathic pain
Read More
Progress reported in Lorantis and PowderJect's allergy collaboration
Read More
Takeda and Albany Molecular Research begin drug discovery research
Read More
FDA approves OTC Claritin for allergies, approvable letter for hives
Read More
Novel insulin mimetics from plant origin described by Suntory
Read More
New factor Xa inhibitors in early development at BMS
Read More
P&G discovers series of melanocortin MC3/MC4 ligands
Read More
Novel beta3-adrenoceptor agonists for obesity, diabetes, etc.
Read More
Japan Tobacco presents new inhibitors of hematopoietic cell phosphatase
Read More
Sumitomo researchers identify new chemopreventive agents
Read More
Kyorin designs new series of potent, selective and orally active human PPARalpha activators
Read More
U.K. team designs potent inhibitors of CDK1/CDK2 as potential anticancer agents
Read More
SAR on a novel series of pyrrolobenzodiazepine antitumor agents
Read More
Aclacinomycin analogues produced by Finnish scientists using combinatorial biosynthesis
Read More
FR-167653, a potential antiinflammatory agent
Read More
Simultaneous inhibition of angiogenesis and tumor growth with human MAb targeting integrins
Read More
Preclinical profile of MEN-91507, a candidate for the treatment of inflammatory diseases
Read More
Data support use of TLK-286 in combination chemotherapy
Read More
Aventis returns dexlipotam rights to Viatris
Read More
YKP-581 selected for advancement
Read More
Kissei licenses KUC-7483 to Boehringer Ingelheim
Read More
MIV Therapeutics and Endovasc form Stentgenix joint venture
Read More
DN-101 evaluated in androgen-independent prostate cancer
Read More